Evidence map›Paper›PMID 41835576›Full record

ArticleACS omega2026

Characterizing Family 1 Glycosyltransferases (GT1, UGT) by Reverse Glycosylation: Fast Determination of Acceptor Specificity, Donor Specificity, Hydrolysis, and Enzyme Stability.

Mads R Langhorn, David Teze

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mads R LanghornThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.ORCID https://orcid.org/0009-0008-2156-6026
David TezeThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.ORCID https://orcid.org/0000-0002-6865-6108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Manufacturing glycoside conjugates through conventional chemistry is a labor-intensive process that involves multiple reaction steps, generates substantial toxic waste, and often results in low yields with poor control over regioselectivity. In contrast, glycosyltransferase family 1 enzymes offer an efficient alternative, enabling the transfer of glycosyl groups in a single step with excellent regioselective control and high yields. However, the factors governing acceptor specificity and the scope of individual enzymes remain unclear, limiting their broader application. To date, there is no widely implemented, low-cost approach to the high-throughput screening of these enzymes. Here, we use reverse glycosylation with 2-chloro-4-nitrophenyl-β-d-glycosides as a generic high-throughput screening method for UGT characterization. We investigate reverse glycosylation kinetics of 34 UGTs and their donor specificity toward the glucose and galactose moieties. Then, the method is utilized in an acceptor screening with 44 acceptors against 32 enzymes, and we determined the

Identifiers

PMID41835576
PMCPMC12984077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.